Join
Live feed
·
PRReleasevia Quantisnow
Aytu BioPharma Inc. logo

Aytu BioPharma Reports Record Quarterly Revenue and Positive Adjusted EBITDA in First Quarter of Fiscal Year 2023

ByQuantisnow·Wall Street's wire, on your screen.
AYTU· Aytu BioPharma Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AYTU (Aytu BioPharma Inc.) and more on Quantisnow.